Emkay Global Financial Recommends Buying Pine Labs, Sets Rs 220 Target

Emkay Global Financial reported that Pine Labs’ revenue was 2.4% above consensus. IAP rose 30.9% year over year and DITP rose 20.8%; contribution margin expanded to 72.8%, while indirect costs increased from the 1Q level.